BELLADONNA, Maria Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.737
EU - Europa 3.102
AS - Asia 2.511
SA - Sud America 412
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 9.828
Nazione #
US - Stati Uniti d'America 3.644
SG - Singapore 1.085
IT - Italia 832
IE - Irlanda 471
CN - Cina 392
HK - Hong Kong 383
UA - Ucraina 358
BR - Brasile 350
VN - Vietnam 325
SE - Svezia 270
DE - Germania 247
RU - Federazione Russa 233
FI - Finlandia 150
RO - Romania 126
FR - Francia 120
KR - Corea 93
GB - Regno Unito 80
CA - Canada 57
IN - India 53
BE - Belgio 39
CZ - Repubblica Ceca 32
JP - Giappone 32
PL - Polonia 29
CH - Svizzera 27
NL - Olanda 27
AR - Argentina 25
MX - Messico 22
TR - Turchia 21
AT - Austria 17
BD - Bangladesh 15
ES - Italia 14
UZ - Uzbekistan 14
CI - Costa d'Avorio 13
EG - Egitto 13
IR - Iran 13
EC - Ecuador 12
ID - Indonesia 11
PK - Pakistan 11
ZA - Sudafrica 10
GR - Grecia 9
IQ - Iraq 8
LB - Libano 8
EU - Europa 7
JO - Giordania 7
MA - Marocco 7
IL - Israele 6
PY - Paraguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
CO - Colombia 4
TN - Tunisia 4
CL - Cile 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DK - Danimarca 2
GA - Gabon 2
JM - Giamaica 2
KH - Cambogia 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
CU - Cuba 1
CV - Capo Verde 1
GD - Grenada 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
Totale 9.826
Città #
Singapore 762
Perugia 507
Chandler 506
Dublin 466
Hong Kong 381
San Mateo 244
Dong Ket 194
Jacksonville 194
Boardman 187
Ashburn 186
Santa Clara 161
Bucharest 118
Beijing 113
Redmond 113
Munich 103
Medford 101
Wilmington 101
Princeton 100
Seoul 90
Ann Arbor 86
Altamura 83
Los Angeles 79
Moscow 78
Lawrence 75
New York 64
Andover 57
Ho Chi Minh City 49
Des Moines 48
Falls Church 45
Brussels 39
Piscataway 37
The Dalles 36
Dearborn 30
São Paulo 30
Turku 30
Helsinki 29
Saint Petersburg 28
Chennai 27
Pisa 26
Tokyo 25
Dallas 24
Warsaw 24
Woodbridge 23
Denver 22
Norwalk 22
Nuremberg 22
Chicago 21
Poplar 20
Atlanta 18
Ottawa 18
San Paolo di Civitate 18
Fremont 17
Brooklyn 16
Boston 15
Brno 15
Hanoi 15
Montreal 15
Stockholm 15
Bologna 14
Houston 14
Olomouc 14
Orem 14
Abidjan 13
Columbus 13
Vicenza 13
Haiphong 12
Lappeenranta 12
Milan 12
Rome 12
San Jose 11
Hefei 10
Izmir 10
London 10
Toronto 10
Falkenstein 9
Parma 9
Phoenix 9
Redwood City 9
San Diego 9
San Francisco 9
Belo Horizonte 8
Johannesburg 8
Seattle 8
Brasília 7
Chiajna 7
Guangzhou 7
Rio de Janeiro 7
Amman 6
Biên Hòa 6
Chengdu 6
Curitiba 6
Den Haag 6
Fortaleza 6
Frankfurt am Main 6
Manchester 6
Mexico City 6
Paris 6
Querétaro 6
Shanghai 6
Tashkent 6
Totale 6.346
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 191
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 180
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 178
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 176
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 166
Amino-acid sensing and degrading pathways in immune regulation 166
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 165
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 160
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 155
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 154
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 137
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 134
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 131
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 129
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 128
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 125
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 120
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 116
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 114
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 114
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 113
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 112
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 112
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 107
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 106
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 105
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 104
The TGF-β/IDO axis in infectious tolerance. 104
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 104
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 103
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 102
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 102
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 100
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 100
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 99
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 98
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance 98
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 96
Modulation of tryptophan catabolism by regulatory T cells 93
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. 93
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 92
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 92
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 90
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 89
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer 89
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 88
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 88
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 87
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 86
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 86
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 85
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents. 84
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 83
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. Maria 82
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 81
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 81
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 81
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 80
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 79
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 79
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 78
CTLA-4-Ig regulates tryptophan catabolism in vivo. 76
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 75
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 74
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 73
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 73
Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. 73
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 73
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 73
The IL-23/IL-17 pathway impairs antifungal immune resistance 72
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. 72
METODO PER LA REALIZZAZIONE DI UNA COMPOSIZIONE PER USO FARMACEUTICO COMPRENDENTE CELLULE DENDRITICHE E COMPOSIZIONE PER USO FARMACEUTICO COSI' OTTENUTA 72
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 71
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 71
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 71
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 71
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 71
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 70
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 69
Current Challenges for IDO2 as Target in Cancer Immunotherapy 69
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. 68
Potentent antitumor activity of interleukin-27. 68
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 68
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 68
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 66
IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. 66
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 66
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 66
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 65
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 65
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. 65
Negative vaccination with IGRP-pulsed dendritic cells expressing ectopic IL-35Ig prevents the development of NOD autoimmune Diabetes 65
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. 64
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 64
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 63
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 63
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. 63
PRODUCTION OF MEMBRANE AND SOLUBLE PD-L1 BY LUNG TUMOR CELLS 63
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 58
IL-23 gene therapy for mouse bladder tumour cell lines. 56
Totale 9.429
Categoria #
all - tutte 43.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 0 65 95 10 109 38 76 209
2021/20221.242 19 179 20 48 55 31 14 276 153 102 117 228
2022/20231.660 112 283 12 153 151 173 1 81 611 17 49 17
2023/2024757 37 92 25 11 11 12 199 22 77 19 88 164
2024/20251.958 47 155 148 118 206 88 128 207 300 109 269 183
2025/20262.326 269 294 237 619 523 384 0 0 0 0 0 0
Totale 10.176